|
| Home : Oral Cancer Therapeutics Market - 51% of Growth to Originate from North America | Driven by Increasing Incidence & Prevalence of Oral Cancer| Technavio |
|
Apr 05
2022 |
Oral Cancer Therapeutics Market - 51% of Growth to Originate from North America | Driven by Increasing Incidence & Prevalence of Oral Cancer| Technavio |
|
NEW YORK, April 5, 2022 /PRNewswire/ -- The Oral Cancer Therapeutics Market offers a comprehensive analysis of new product launches, the latest trends, drivers, and challenges. The oral cancer therapeutics market value is set to grow by USD 1.14 billion from 2021 to 2026. However, the... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/oral-cancer-therapeutics-market---51-of-growth-to-originate-from-north-america--driven-by-increasing-incidence--prevalence-of-oral-cancer-technavio-301516828.html |
| |
|
Related News
|
» Emerald Coast Restaurant Brokers and Consultants Launches New Website
» Invitation to media and analyst briefing for Ericsson Q1 2022 report
|
|
|
